JATPHARMA in Kobe: Black box no more: Psychiatrists using their expertise against diseases of the mind
Dr. Shuken Boku, a neuroscientist and psychiatrist at Kobe University, will speak about his research into the pathogenesis of mood disorders while providing a general introduction on mental illness. Dr. Tsukasa Ikegami, a Jungian psychiatrist, will use behavioral models to describe schizophrenia and its treatment. We hope you will join us for this not-to-be-missed opportunity!
April 15, 2017, @ the Sannomiya Convention Center in Kobe, a 5-minute walk from most of the main Sannomiya stations.
Fee: Non-JAT-members: 4000 yen (4500 yen after 6:00 p.m. on April 3), JAT members: 3000 (3500 yen after 6:00 p.m. on April 3) (pay using Eventbrite form at bottom of page)
Registration questions? Contact us at [email protected]
Doors open for registration: 13:00
13:10-14:00 Pharmacokinetic Expressions workshop (led by Sako Ikegami, PharmD)
14:00-14:20 Short break for networking
14:20-15:30 So what’s crazy, Doc? Dr. Shuken Boku, MD, PhD
15:30-16:30 Schizophrenia—the name says it all Dr. Tsukasa Ikegami, MD
16:30-17:00 Discussion btw Dr. Boku and Dr. Ikegami
17:45- Dinner reception (approximately 5000 yen, location TBA. You must register by 6:00 p.m. on Monday, April 3 to secure a spot. We'll inform you of the location and cost soon thereafter.)
We will not know how much discussion time we will have until the actual day, but we welcome questions in advance from participants for our speakers. Please address your questions to (psych-Q ‘at’ sakotrans.com)
Speaker profiles:
Shuken Boku, MD, PhD, a native of Sakai, Osaka, graduated from the Faculty of Medicine at Kyoto U. in 1998 and focused in molecular biology as a visiting researcher at the Max Planck Institute in Dortmund, Germany. He later decided to practice psychiatry, and joined the Department of Psychiatry at Hokkaido University Hospital. While there, he worked in a broad range of clinical settings, and spent another year abroad at the Albert Einstein College of Medicine in New York researching the 22q11.2 chromosome and its associations with autism spectrum disorders and schizophrenia. As of 2014, he is a lecturer at the Psychiatry and Neurology department at Kobe University Hospital. His focus is basic research to establish novel insights into the pathogenesis of mental illness that goes beyond the ages-old neurotransmitter theories, while remaining an active clinician.
Tsukasa Ikegami, MD from Kyoto, graduated from Kyoto U. in 1984, specializing in psychiatry. He trained as a Jungian analyst at the CG Jung Institute in Zurich, and received his Jungian diploma in 2001. He has practiced in a broad range of settings including a psychiatric hospital, a mental clinic, IMD (Lausanne, CH), and a leading corporation. He also heads the Stress Counseling Office for university staff at Osaka Prefectural U. and has a private practice at the Ikegami Clinic Counseling Office in Ashiya. His focus is Jungian psychoanalysis and psychotherapy, employing sandplay, art therapy, dream analysis, and other forms of counseling to support his patients through to remission.
Sako Ikegami, who completed her graduate-level PharmD at the Massachusetts College of Pharmacy in Boston, is a freelance med/pharma communicator, providing interpretation, translation, and medical writing services. She has worked in pharmacokinetics (Phase I) at a pharma company, and wrote her doctorate thesis based on comparative leucovorin bioavailability in healthy volunteers at the Dana Farber Cancer Institute, but has forgotten all those nasty formulas by now.